This announcement is a separate document:
诺诚健华医药有限公司自愿披露关于奥布替尼临床试验进展的公告
Nuochengjianhua Pharmaceutical Co., Ltd. voluntarily disclosed the progress of clinical trials of obutinib
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.